Compound Q&A
What is the market or research trend for L-Valyl-L-glutaminylglycyl-L-alpha-glutamyl-L-alpha-glutamyl-L-seryl-L-asparaginyl-L-alpha-aspartyl-L-lysine (CAS: 106021-96-9)?
Answer
The market for L-Valyl-L-glutaminylglycyl-L-alpha-glutamyl-L-alpha-glutamyl-L-seryl-L-asparaginyl-L-alpha-aspartyl-L-lysine (CAS: 106021-96-9) is driven by its applications in pharmaceuticals and research. Recent trends show an increase in demand for custom peptide synthesis services, particularly in areas like drug discovery and proteomics. Research is also focusing on its potential in biotechnology and biomedical applications, leading to emerging opportunities in the field.
About
CAS No
106021-96-9
English Name
L-Valyl-L-glutaminylglycyl-L-alpha-glutamyl-L-alpha-glutamyl-L-seryl-L-asparaginyl-L-alpha-aspartyl-L-lysine
Molecular Formula
C39H64N12O19
Molecular Weight
1005.01 g/mol
SMILES
CC(C)C(C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)O)N
InChIKey
NIXBZDOQHRZFDR-OEWCNXHOSA-N
Last Updated: 2026-01-02 12:18
